DOI: 10.1016/s0022-5347(17)35032-2. Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy

Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy

10.1016/s0022-5347(17)35032-2

Crossref journal-article

Ovid Technologies (Wolters Kluwer Health)

Journal of Urology (276)

Bibliography

Sanda, M. G., Ayyagari, S. R., Jaffee, E. M., Epstein, J. I., Clift, S. L., Cohen, L. K., Dranoff, G., Pardoll, D. M., Mulligan, R. C., & Simons, J. W. (1994). Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy. Journal of Urology, 151(3), 622â628.

Authors 10

Martin G. Sanda (first)
Sujatha R. Ayyagari (additional)
Elizabeth M. Jaffee (additional)
Jonathan I. Epstein (additional)
Shirley L. Clift (additional)
Lawrence K. Cohen (additional)
Glenn Dranoff (additional)
Drew M. Pardoll (additional)
Richard C. Mulligan (additional)
Jonathan W. Simons (additional)

References 38 Referenced 177

{'key': '10.1016/S0022-5347(17)35032-2_bib1', 'first-page': '7', 'article-title': 'Cancer statistics, 1993', 'volume': '43', 'author': 'Boring', 'year': '1993', 'journal-title': 'CA'} / CA / Cancer statistics, 1993 by Boring (1993)
10.1056/NEJM198710083171501 / New Engl. J. Med. / Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate by Stamey (1987)
10.1016/S0022-5347(17)41037-8 / J. Urol. / The value of serum prostate specific antigen deteriminations before and after radical prostatectomy by Lange (1989)
10.1056/NEJM199104253241702 / New Engl. J. Med. / Measurement of prostate-specific antigen in serum as a screening test for prostate cancer by Catalona (1991)
10.1056/NEJM199101243240406 / New Engl. J. Med. / Carcinoma of the prostate by Gittes (1991)
10.1002/pros.2990160105 / Prostate / The prostate: an increasing medical problem by Carter (1990)
10.1016/S0022-5347(17)74226-7 / J. Urol. / The cultivation of bladder and prostate tumors outside the body by Burrows (1917)
10.1016/0092-8674(89)90925-2 / Cell / Murine interleukin-4 displays potent antitumor activity in vivo by Tepper (1989)
10.1016/0092-8674(90)90591-2 / Cell / Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response by Fearon (1990)
10.1126/science.1948050 / Science / Treatment of established renal cell cancer by tumor cells engineered to secrete interleukin-4 by Golumbek (1991)
10.4049/jimmunol.146.9.3227 / J. Immunol. / Murine tumor cells transduced with the gene from tumor necrosis factor alpha. Evidence for paracrine immune effects of tumor necrosis factor alpha against tumors by Asher (1991)
{'key': '10.1016/S0022-5347(17)35032-2_bib12', 'first-page': '3679', 'article-title': 'Interleukin 6 gene transfection into Lewis lung carcinoma cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells', 'volume': '52', 'author': 'Porgador', 'year': '1992', 'journal-title': 'Cancer Res.'} / Cancer Res. / Interleukin 6 gene transfection into Lewis lung carcinoma cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells by Porgador (1992)
10.1016/S0092-8674(05)80059-5 / Cell / Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 by Chen (1992)
10.1073/pnas.86.23.9456 / Proc. Natl. Acad. Sci. / Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented antitumor immunity by Wantanabe (1989)
{'key': '10.1016/S0022-5347(17)35032-2_bib15', 'first-page': '7820', 'article-title': 'Retroviral vector-mediated gamma interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity', 'volume': '50', 'author': 'Gansbacher', 'year': '1990', 'journal-title': 'Cancer Res.'} / Cancer Res. / Retroviral vector-mediated gamma interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity by Gansbacher (1990)
10.1084/jem.175.6.1423 / J. Exp. Med. / A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability by Restifo (1992)
10.1073/pnas.90.8.3539 / Proc. Natl. Acad. Sci. / Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity by Dranoff (1993)
10.1126/science.8418502 / Science / Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA by Trojan (1993)
{'key': '10.1016/S0022-5347(17)35032-2_bib19', 'series-title': 'Etiology of Human Diseases at the DNA Level', 'first-page': '143', 'article-title': 'Gene transfer and gene therapy', 'author': 'Mulligan', 'year': '1991'} / Etiology of Human Diseases at the DNA Level / Gene transfer and gene therapy by Mulligan (1991)
10.1073/pnas.85.17.6460 / Proc. Natl. Acad. Sci. / Safe and efficient generation of recombinant retrovirus with amphotropic and ecotropic host ranges by Danos (1988)
Simons, J. W.: Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. NIH Recombinant DNA Advisory Committee Protocol, 1993.
{'key': '10.1016/S0022-5347(17)35032-2_bib22', 'first-page': '2221', 'article-title': 'High efficiency gene transfer into primary human tumor explants without cell selection', 'volume': '53', 'author': 'Jaffee', 'year': '1993', 'journal-title': 'Cancer Res.'} / Cancer Res. / High efficiency gene transfer into primary human tumor explants without cell selection by Jaffee (1993)
{'key': '10.1016/S0022-5347(17)35032-2_bib23', 'series-title': 'Culture of Epithelial Cells', 'first-page': '159', 'article-title': 'Culture of human prostatic epithelial cells', 'author': 'Peehl', 'year': '1992'} / Culture of Epithelial Cells / Culture of human prostatic epithelial cells by Peehl (1992)
{'key': '10.1016/S0022-5347(17)35032-2_bib24', 'first-page': '6182', 'article-title': 'Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer', 'volume': '52', 'author': 'Verhagen', 'year': '1992', 'journal-title': 'Cancer Res.'} / Cancer Res. / Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer by Verhagen (1992)
{'key': '10.1016/S0022-5347(17)35032-2_bib25', 'first-page': '576', 'article-title': 'A simple assay for DNA transformation by incubation of the cells in culture dishes with substrates for beta-galactosidase', 'volume': '7', 'author': 'Lim', 'year': '1989', 'journal-title': 'Biotechniques'} / Biotechniques / A simple assay for DNA transformation by incubation of the cells in culture dishes with substrates for beta-galactosidase by Lim (1989)
{'key': '10.1016/S0022-5347(17)35032-2_bib26', 'series-title': 'Molecular Cloning: A Laboratory Manual', 'article-title': 'Isolation of DNA from mammalian cells: protocol I', 'author': 'Sambrook', 'year': '1989'} / Molecular Cloning: A Laboratory Manual / Isolation of DNA from mammalian cells: protocol I by Sambrook (1989)
{'key': '10.1016/S0022-5347(17)35032-2_bib27', 'first-page': '15', 'article-title': 'Transforming growth-factor beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro', 'volume': '6', 'author': 'Steiner', 'year': '1992', 'journal-title': 'Mol. Endocr.'} / Mol. Endocr. / Transforming growth-factor beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro by Steiner (1992)
Moody, D. B., Robinson, J. C., Ewing, C. M., Lazenby, A. J. and Isaacs, W. B.: Interleukin-2 transfected prostate cancer cells generate a local anti-tumor effect in vivo. Prostate, in press.
{'key': '10.1016/S0022-5347(17)35032-2_bib29', 'first-page': '3795', 'article-title': 'Frequency and pattern of karyotypic abnormalities in human prostate cancer', 'volume': '50', 'author': 'Brothman', 'year': '1990', 'journal-title': 'Cancer Res.'} / Cancer Res. / Frequency and pattern of karyotypic abnormalities in human prostate cancer by Brothman (1990)
10.1016/0165-4608(92)90259-B / Cancer Genet. Cytogenet. / Analysis of prostatic tumor cultures using fluorescence insitu hybridization (FISH) by Brothman (1992)
{'key': '10.1016/S0022-5347(17)35032-2_bib31', 'first-page': '5074S', 'article-title': 'Immunotherapy and gene therapy of cancer', 'volume': '51', 'author': 'Rosenberg', 'year': '1991', 'journal-title': 'Cancer Res.'} / Cancer Res. / Immunotherapy and gene therapy of cancer by Rosenberg (1991)
10.1126/science.1589762 / Science / Human gene therapy by Anderson (1992)
10.1093/jnci/85.3.207 / J. Natl. Cancer Inst. / Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha genes: implications for live cancer vaccines by Belledegrun (1993)
{'key': '10.1016/S0022-5347(17)35032-2_bib34', 'first-page': '6229', 'article-title': 'Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells', 'volume': '52', 'author': 'Gastl', 'year': '1992', 'journal-title': 'Cancer Res.'} / Cancer Res. / Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells by Gastl (1992)
10.1126/science.8493530 / Science / The basic science of gene therapy by Mulligan (1993)
{'key': '10.1016/S0022-5347(17)35032-2_bib36', 'first-page': '7', 'article-title': 'Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase', 'volume': '94', 'author': 'Svanholm', 'year': '1986', 'journal-title': 'Acta Path. Microbiol. Immunol. Scand. A'} / Acta Path. Microbiol. Immunol. Scand. A / Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase by Svanholm (1986)
10.1093/ajcp/81.3.279 / Amer. J. Clin. Path. / Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate by Ellis (1984)
10.1016/S0022-5347(17)40079-6 / J. Urol. / Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume, and benign hyperplasia by Partin (1990)

Dates

Type	When
Created	8 years, 2 months ago (June 30, 2017, 1:03 a.m.)
Deposited	2 years ago (Aug. 24, 2023, 2:59 a.m.)
Indexed	2 months, 1 week ago (June 21, 2025, 12:12 a.m.)
Issued	31 years, 6 months ago (March 1, 1994)
Published	31 years, 6 months ago (March 1, 1994)
Published Print	31 years, 6 months ago (March 1, 1994)

Funders 0

None

BibTeX

@article{Sanda_1994, title={Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy}, volume={151}, ISSN={1527-3792}, url={http://dx.doi.org/10.1016/s0022-5347(17)35032-2}, DOI={10.1016/s0022-5347(17)35032-2}, number={3}, journal={Journal of Urology}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Sanda, Martin G. and Ayyagari, Sujatha R. and Jaffee, Elizabeth M. and Epstein, Jonathan I. and Clift, Shirley L. and Cohen, Lawrence K. and Dranoff, Glenn and Pardoll, Drew M. and Mulligan, Richard C. and Simons, Jonathan W.}, year={1994}, month=mar, pages={622–628} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        6,
        21
      ]
    ],
    "date-time": "2025-06-21T04:12:06Z",
    "timestamp": 1750479126677
  },
  "reference-count": 38,
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "issue": "3",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1994,
            3,
            1
          ]
        ],
        "date-time": "1994-03-01T00:00:00Z",
        "timestamp": 762480000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1994,
        3
      ]
    ]
  },
  "DOI": "10.1016/s0022-5347(17)35032-2",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2017,
        6,
        30
      ]
    ],
    "date-time": "2017-06-30T05:03:13Z",
    "timestamp": 1498798993000
  },
  "page": "622-628",
  "source": "Crossref",
  "is-referenced-by-count": 177,
  "title": "Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy",
  "prefix": "10.1097",
  "volume": "151",
  "author": [
    {
      "given": "Martin G.",
      "family": "Sanda",
      "sequence": "first",
      "affiliation": [
        {
          "name": "From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"
        },
        {
          "name": "Somatix Therapy Corporation, Alameda, California"
        },
        {
          "name": "Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts"
        }
      ]
    },
    {
      "given": "Sujatha R.",
      "family": "Ayyagari",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"
        },
        {
          "name": "Somatix Therapy Corporation, Alameda, California"
        },
        {
          "name": "Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts"
        }
      ]
    },
    {
      "given": "Elizabeth M.",
      "family": "Jaffee",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"
        },
        {
          "name": "Somatix Therapy Corporation, Alameda, California"
        },
        {
          "name": "Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts"
        }
      ]
    },
    {
      "given": "Jonathan I.",
      "family": "Epstein",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"
        },
        {
          "name": "Somatix Therapy Corporation, Alameda, California"
        },
        {
          "name": "Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts"
        }
      ]
    },
    {
      "given": "Shirley L.",
      "family": "Clift",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"
        },
        {
          "name": "Somatix Therapy Corporation, Alameda, California"
        },
        {
          "name": "Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts"
        }
      ]
    },
    {
      "given": "Lawrence K.",
      "family": "Cohen",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"
        },
        {
          "name": "Somatix Therapy Corporation, Alameda, California"
        },
        {
          "name": "Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts"
        }
      ]
    },
    {
      "given": "Glenn",
      "family": "Dranoff",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"
        },
        {
          "name": "Somatix Therapy Corporation, Alameda, California"
        },
        {
          "name": "Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts"
        }
      ]
    },
    {
      "given": "Drew M.",
      "family": "Pardoll",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"
        },
        {
          "name": "Somatix Therapy Corporation, Alameda, California"
        },
        {
          "name": "Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts"
        }
      ]
    },
    {
      "given": "Richard C.",
      "family": "Mulligan",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"
        },
        {
          "name": "Somatix Therapy Corporation, Alameda, California"
        },
        {
          "name": "Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts"
        }
      ]
    },
    {
      "given": "Jonathan W.",
      "family": "Simons",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"
        },
        {
          "name": "Somatix Therapy Corporation, Alameda, California"
        },
        {
          "name": "Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts"
        }
      ]
    }
  ],
  "member": "276",
  "reference": [
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib1",
      "first-page": "7",
      "article-title": "Cancer statistics, 1993",
      "volume": "43",
      "author": "Boring",
      "year": "1993",
      "journal-title": "CA"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "909",
      "DOI": "10.1056/NEJM198710083171501",
      "article-title": "Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate",
      "volume": "317",
      "author": "Stamey",
      "year": "1987",
      "journal-title": "New Engl. J. Med."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "873",
      "DOI": "10.1016/S0022-5347(17)41037-8",
      "article-title": "The value of serum prostate specific antigen deteriminations before and after radical prostatectomy",
      "volume": "141",
      "author": "Lange",
      "year": "1989",
      "journal-title": "J. Urol."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "1156",
      "DOI": "10.1056/NEJM199104253241702",
      "article-title": "Measurement of prostate-specific antigen in serum as a screening test for prostate cancer",
      "volume": "324",
      "author": "Catalona",
      "year": "1991",
      "journal-title": "New Engl. J. Med."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "236",
      "DOI": "10.1056/NEJM199101243240406",
      "article-title": "Carcinoma of the prostate",
      "volume": "324",
      "author": "Gittes",
      "year": "1991",
      "journal-title": "New Engl. J. Med."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "39",
      "DOI": "10.1002/pros.2990160105",
      "article-title": "The prostate: an increasing medical problem",
      "volume": "16",
      "author": "Carter",
      "year": "1990",
      "journal-title": "Prostate"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "DOI": "10.1016/S0022-5347(17)74226-7",
      "article-title": "The cultivation of bladder and prostate tumors outside the body",
      "volume": "1",
      "author": "Burrows",
      "year": "1917",
      "journal-title": "J. Urol."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "503",
      "DOI": "10.1016/0092-8674(89)90925-2",
      "article-title": "Murine interleukin-4 displays potent antitumor activity in vivo",
      "volume": "57",
      "author": "Tepper",
      "year": "1989",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "397",
      "DOI": "10.1016/0092-8674(90)90591-2",
      "article-title": "Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response",
      "volume": "60",
      "author": "Fearon",
      "year": "1990",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "713",
      "DOI": "10.1126/science.1948050",
      "article-title": "Treatment of established renal cell cancer by tumor cells engineered to secrete interleukin-4",
      "volume": "254",
      "author": "Golumbek",
      "year": "1991",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "3227",
      "DOI": "10.4049/jimmunol.146.9.3227",
      "article-title": "Murine tumor cells transduced with the gene from tumor necrosis factor alpha. Evidence for paracrine immune effects of tumor necrosis factor alpha against tumors",
      "volume": "146",
      "author": "Asher",
      "year": "1991",
      "journal-title": "J. Immunol."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib12",
      "first-page": "3679",
      "article-title": "Interleukin 6 gene transfection into Lewis lung carcinoma cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells",
      "volume": "52",
      "author": "Porgador",
      "year": "1992",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "1093",
      "DOI": "10.1016/S0092-8674(05)80059-5",
      "article-title": "Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4",
      "volume": "71",
      "author": "Chen",
      "year": "1992",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "9456",
      "DOI": "10.1073/pnas.86.23.9456",
      "article-title": "Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented antitumor immunity",
      "volume": "86",
      "author": "Wantanabe",
      "year": "1989",
      "journal-title": "Proc. Natl. Acad. Sci."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib15",
      "first-page": "7820",
      "article-title": "Retroviral vector-mediated gamma interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity",
      "volume": "50",
      "author": "Gansbacher",
      "year": "1990",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "1423",
      "DOI": "10.1084/jem.175.6.1423",
      "article-title": "A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability",
      "volume": "175",
      "author": "Restifo",
      "year": "1992",
      "journal-title": "J. Exp. Med."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "3539",
      "DOI": "10.1073/pnas.90.8.3539",
      "article-title": "Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity",
      "volume": "90",
      "author": "Dranoff",
      "year": "1993",
      "journal-title": "Proc. Natl. Acad. Sci."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "94",
      "DOI": "10.1126/science.8418502",
      "article-title": "Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA",
      "volume": "259",
      "author": "Trojan",
      "year": "1993",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib19",
      "series-title": "Etiology of Human Diseases at the DNA Level",
      "first-page": "143",
      "article-title": "Gene transfer and gene therapy",
      "author": "Mulligan",
      "year": "1991"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "6460",
      "DOI": "10.1073/pnas.85.17.6460",
      "article-title": "Safe and efficient generation of recombinant retrovirus with amphotropic and ecotropic host ranges",
      "volume": "85",
      "author": "Danos",
      "year": "1988",
      "journal-title": "Proc. Natl. Acad. Sci."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib21",
      "unstructured": "Simons, J. W.: Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. NIH Recombinant DNA Advisory Committee Protocol, 1993."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib22",
      "first-page": "2221",
      "article-title": "High efficiency gene transfer into primary human tumor explants without cell selection",
      "volume": "53",
      "author": "Jaffee",
      "year": "1993",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib23",
      "series-title": "Culture of Epithelial Cells",
      "first-page": "159",
      "article-title": "Culture of human prostatic epithelial cells",
      "author": "Peehl",
      "year": "1992"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib24",
      "first-page": "6182",
      "article-title": "Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer",
      "volume": "52",
      "author": "Verhagen",
      "year": "1992",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib25",
      "first-page": "576",
      "article-title": "A simple assay for DNA transformation by incubation of the cells in culture dishes with substrates for beta-galactosidase",
      "volume": "7",
      "author": "Lim",
      "year": "1989",
      "journal-title": "Biotechniques"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib26",
      "series-title": "Molecular Cloning: A Laboratory Manual",
      "article-title": "Isolation of DNA from mammalian cells: protocol I",
      "author": "Sambrook",
      "year": "1989"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib27",
      "first-page": "15",
      "article-title": "Transforming growth-factor beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro",
      "volume": "6",
      "author": "Steiner",
      "year": "1992",
      "journal-title": "Mol. Endocr."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib28",
      "unstructured": "Moody, D. B., Robinson, J. C., Ewing, C. M., Lazenby, A. J. and Isaacs, W. B.: Interleukin-2 transfected prostate cancer cells generate a local anti-tumor effect in vivo. Prostate, in press."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib29",
      "first-page": "3795",
      "article-title": "Frequency and pattern of karyotypic abnormalities in human prostate cancer",
      "volume": "50",
      "author": "Brothman",
      "year": "1990",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "180",
      "DOI": "10.1016/0165-4608(92)90259-B",
      "article-title": "Analysis of prostatic tumor cultures using fluorescence insitu hybridization (FISH)",
      "volume": "62",
      "author": "Brothman",
      "year": "1992",
      "journal-title": "Cancer Genet. Cytogenet."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib31",
      "first-page": "5074S",
      "article-title": "Immunotherapy and gene therapy of cancer",
      "volume": "51",
      "author": "Rosenberg",
      "year": "1991",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "808",
      "DOI": "10.1126/science.1589762",
      "article-title": "Human gene therapy",
      "volume": "256",
      "author": "Anderson",
      "year": "1992",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "207",
      "DOI": "10.1093/jnci/85.3.207",
      "article-title": "Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha genes: implications for live cancer vaccines",
      "volume": "85",
      "author": "Belledegrun",
      "year": "1993",
      "journal-title": "J. Natl. Cancer Inst."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib34",
      "first-page": "6229",
      "article-title": "Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells",
      "volume": "52",
      "author": "Gastl",
      "year": "1992",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib35",
      "doi-asserted-by": "crossref",
      "first-page": "926",
      "DOI": "10.1126/science.8493530",
      "article-title": "The basic science of gene therapy",
      "volume": "260",
      "author": "Mulligan",
      "year": "1993",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib36",
      "first-page": "7",
      "article-title": "Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase",
      "volume": "94",
      "author": "Svanholm",
      "year": "1986",
      "journal-title": "Acta Path. Microbiol. Immunol. Scand. A"
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "279",
      "DOI": "10.1093/ajcp/81.3.279",
      "article-title": "Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate",
      "volume": "81",
      "author": "Ellis",
      "year": "1984",
      "journal-title": "Amer. J. Clin. Path."
    },
    {
      "key": "10.1016/S0022-5347(17)35032-2_bib38",
      "doi-asserted-by": "crossref",
      "first-page": "747",
      "DOI": "10.1016/S0022-5347(17)40079-6",
      "article-title": "Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume, and benign hyperplasia",
      "volume": "143",
      "author": "Partin",
      "year": "1990",
      "journal-title": "J. Urol."
    }
  ],
  "container-title": "Journal of Urology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0022534717350322?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0022534717350322?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2935032-2",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        8,
        24
      ]
    ],
    "date-time": "2023-08-24T06:59:21Z",
    "timestamp": 1692860361000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "http://www.jurology.com/doi/10.1016/S0022-5347%2817%2935032-2"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1994,
        3
      ]
    ]
  },
  "references-count": 38,
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          1994,
          3
        ]
      ]
    }
  },
  "alternative-id": [
    "10.1016/S0022-5347(17)35032-2"
  ],
  "URL": "http://dx.doi.org/10.1016/S0022-5347(17)35032-2",
  "relation": {},
  "ISSN": [
    "0022-5347",
    "1527-3792"
  ],
  "subject": [],
  "container-title-short": "Journal of Urology",
  "published": {
    "date-parts": [
      [
        1994,
        3
      ]
    ]
  }
}